Advanced Search

Study Preview



Study Title and Description

Defeating Urinary Incontinence with Exercise Training: Results of a Pilot Study in Frail Older Women.



Key Questions Addressed
1 KQ 1: What are the benefits and harms of nonpharmacological treatments of UI in women, and how do they compare with each other? KQ 2: What are the benefits and harms of pharmacological treatments of UI in women, and how do they compare with each other? KQ 3: What are the comparative benefits and harms of nonpharmacological versus pharmacological treatments of UI in women? KQ 4: What are the benefits and harms of combined nonpharmacological and pharmacological treatment of UI in women?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Defeating Urinary Incontinence with Exercise Training: Results of a Pilot Study in Frail Older Women.
Author Talley KMC., Wyman JF., Bronas U., Olson-Kellogg BJ., McCarthy TC.
Country School of Nursing, University of Minnesota, Minneapolis, Minnesota.
Year 2017
Numbers Pubmed ID: 28248418

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: All studies
Arms
Number Title Description Comments
1 Behavioral and phsyical activity
  • Comments Comments (
    0
    ) |
2 Placebo
  • Comments Comments (
    0
    ) |

Design Details
Question... Follow Up Answer Follow-up Answer
Study type RCT
  • Comments Comments (
    0
    ) |
Country/countries US
  • Comments Comments (
    0
    ) |
Funding source Explicitly not industry funded
  • Comments Comments (
    0
    ) |
Inclusion criteria UI (score of ≥1 points on the International Consultation on Incontinence Questionnaire (ICIQ)),13 being frail (score of ≥3 points on the Vulnerable Elders Survey), gait speed less than 0.8 m/s15 or using a walking assistive device, being able to participate safely in low intensity physical activity, being cognitively intact according to Mini-Cog score
  • Comments Comments (
    0
    ) |
Exclusion criteria UI associated with a central nervous system disorder, bladder cancer, recent bladder or incontinence surgery, or terminal illness, or if they had an ostomy, used a pessary or urinary catheter, started or changed the dose of an antiincontinence medication within 3 months, or had orthopedic surgery on the lower extremities or spine in the past year.
  • Comments Comments (
    0
    ) |
UI type 22
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
14
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
62
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
Age 84.9
  • Comments Comments (
    0
    ) |
mean
  • Comments Comments (
    0
    ) |
6.4
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
Men included 0
  • Comments Comments (
    0
    ) |
Special populations 42
  • Comments Comments (
    0
    ) |
100
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
Race
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
41
  • Comments Comments (
    0
    ) |
98
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
  • Comments Comments (
    0
    ) |
Notes
  • Comments Comments (
    0
    ) |
Did participants fail previous treatment? Not reported/unclear
  • Comments Comments (
    0
    ) |
Study years 2012-2015
  • Comments Comments (
    0
    ) |
Trial name (if given) ND
  • Comments Comments (
    0
    ) |
Does this paper cite a previous paper from the same study? NO
  • Comments Comments (
    0
    ) |


Baseline Characteristics
Question Behavioral and phsyical activity Placebo Total Comments
AnswerFollow-up AnswerFollow-up AnswerFollow-up
Participant flow 23 19 42
  • Comments Comments (
    0
    ) |
23 19 42
  • Comments Comments (
    0
    ) |
0 0 0
  • Comments Comments (
    0
    ) |
Notes No data entered.



Results & Comparisons


Results Data
Outcome: Cure etc.      Population: All Participants
Time Point Measure Behavioral and phsyical activity Placebo


12 weeks

N Analyzed 23 19
Counts 13 3
Outcome: Satisfaction with intervention      Population: All Participants
Time Point Measure Behavioral and phsyical activity Placebo


12 weeks

N Analyzed 23 19
Counts 19 7


Quality Dimensions
Dimension Value Notes Comments
RCT:.....Adequate generation of a randomized sequence Low RoB
  • Comments Comments (
    0
    ) |
RCT:.....Allocation concealment Low RoB
  • Comments Comments (
    0
    ) |
RCT:.....Blinding of PATIENTS High RoB patients were not blinded
  • Comments Comments (
    0
    ) |
RCT.....Intention-to-treat-analysis Low RoB
  • Comments Comments (
    0
    ) |
ALL.....Blinding of OUTCOME ASSESSORS (or "DOUBLE BLIND") Low RoB
  • Comments Comments (
    0
    ) |
ALL.....Incomplete results data (attrition bias) Low RoB
  • Comments Comments (
    0
    ) |
ALL....Group similarity at baseline (selection bias) Low RoB
  • Comments Comments (
    0
    ) |
ALL.....Compliance with interventions Low RoB
  • Comments Comments (
    0
    ) |
NRCS.....Patients in different intervention groups selected in an equivalent manner Yes
  • Comments Comments (
    0
    ) |
NRCS....Baseline differences between groups accounted for (Adjusted analysis)? Not Applicable
  • Comments Comments (
    0
    ) |
ALL.....Other issues Not Applicable
  • Comments Comments (
    0
    ) |
ALL....Were interventions adequately described? Yes
  • Comments Comments (
    0
    ) |

Quality Rating
Guideline Used Overall Rating